: Treatment Protocol for Uremic Neuropathy in ESRD
Renal Palliative Care Initiative: Treatment Protocol for Uremic Neuropathy
This treatment protocol was created to address and manage occurrence of uremic
neuropathy in patients with end stage renal disease.
Clinical Care Tools - Symptom Management
Renal Palliative Care Initiative
Baystate Medical Center
759 Chestnut Street S2669
Springfield, MA 01199
Michael Germain, M.D.
How the grantee used this instrument:
This protocol was made available at the clinics and renal unit nursing stations.
esrd, end stage renal disease, uremic neuropathy, dialysis, kidney disease, symptom
To use this tool:
You may print and copy this tool for your own use from this site. Please credit
- Callaghan, N. "Restless legs symdrome in uremic neuropathy." Neurology,
1966; 16: 359.
- Walker, S., Fine, A., & Kryger, M.H. "Sleep complaints are
common in a dialysis unit." American Journal of Kidney Diseases, 1995; 26:751.
- Harris, DC, Chapman,
JR, Stewart, KH, et al. "Low dose erythropoietin in maintenance hemodialysis:
Improvement in quality of life and reduction in
true cost of hemodialysis."
Australian & New Zealand Journal of Medicine, 1991; 21:693.
- Roger, SD, Harris, DCH, & Stewart, JH. "Possible
relation between restless legs and anaemia in renal dialysis patients." Lancet,
- O'Keefe, St, Gavin, K, Lavan, JN. "Iron status and restless leg
syndrome in the elderly." Age Ageing, 1994;23:200.
- Collado-Seidel, V, Kohnen,
R, Samtleben, W, et al. "Clinical and biochemical findings in uremic patients
with and without restless legs syndrome." American Journal of Kidney
Diseases, 1998; 31:132.
- Winkelman, JW, Cherow, GM, & Lazarus, JM. "Restless
legs syndrome in end-stage renal disease." American Journal of Kidney
Diseases, 1996; 28: 372.
WA. "Therapeutic approaches to restless legs syndrome and periodic limb movement
disorder." Hospital Medicine, 1997; 33: 135.
- Schenck, CH, Mahowald, MW. "Long-term,
nightly benzodiazepine treatment of injurious parasomnias and other disorders
of disrupted nocturnal sleep
adults." American Journal of Medicine,1996; 100:333
- Allen, RP, & Earley, CJ, "Augmentation of
the restless lege syndrome with carbidopa/levodopa." Journal of Sleep
Research, 1996; 19: 205.
Scheele, C, Kempe, V. "Long-term effect of dopaminergic drugs in restless
legs: A 2-year follow-up." Archives of Neurology, 1990; 47:1223.
- Silber, MH, Shepart,
JW Jr, Wisbey, JA. "Pergolide in the management of restless legs syndrome:
An extended study." Journal of Sleep Research, 1997; 20:878.
- Thorp, ML, Morris, CD, Bagby, SP.
"A crossover study of gabapentim in treatment of restless legs syndrome
among hemodialysis patients." American Journal of Kidney Diseases, 2001;38:104.
- Wagner, ML, Walters, AS, Coleman, et.al. "Randomized,
double-blind, placebo-controlled study of clonidine in restless legs syndrome."
- Walters, AS, Wagner, ML, Hening, WA, et al. "Successful treatment
of the idiopathic restless legs syndrome in a randomized double-blind
placebo." Journal of Sleep Research, 1993; 16:327.
To view this tool:
Left click on the download link to view the PDF document in your Web browser.
Right-click on the download link to save the document to your computer.
65 KB / 1 page (Viewing PDF files requires downloading
and installation of the free Adobe
Posted April 2004
Baystate Medical Center overview page
# BMC13, type:symptom_management
Promoting Excellence in End-of-Life Care is a national program of The Robert Wood Johnson Foundation dedicated to long-term changes in health care institutions to substantially improve care for dying people and their families. Visit PromotingExcellence.org for more resources.